Literature DB >> 10690726

Cowden disease and Lhermitte-Duclos disease: characterization of a new phakomatosis.

S Robinson1, A R Cohen.   

Abstract

OBJECTIVE: Lhermitte-Duclos disease, or dysplastic gangliocytoma of the cerebellum, is an unusual hamartomatous lesion that can cause progressive mass effects in the posterior fossa. Cowden disease, or multiple hamartoma-neoplasia syndrome, is a rare autosomal dominant disorder characterized by mucocutaneous hamartomas and high incidences of systemic malignancies. We recently treated a patient with manifestations of both Lhermitte-Duclos disease and Cowden disease, and we were intrigued by the occurrence of these two rare disorders in the same patient. The purpose of the present study was to examine the nature of the association between Lhermitte-Duclos disease and Cowden disease.
METHODS: The records for all patients who had been diagnosed at our institution as having Lhermitte-Duclos disease were reviewed, to determine whether these patients also exhibited manifestations of Cowden disease. Data were obtained from multiple sources, including patient interviews, correspondence with treating physicians, and chart reviews.
RESULTS: During the past 40 years, five patients were diagnosed at Case Western Reserve University as having Lhermitte-Duclos disease. All five patients exhibited manifestations of Cowden disease. Before this review, Cowden disease had not been diagnosed for three of the patients. In our most recent case, the diagnoses of both disorders were established preoperatively. That patient was observed to have a deletion in the critical portion of Exon 5 of the PTEN gene, the gene associated with Cowden disease.
CONCLUSION: Inclusion of Lhermitte-Duclos disease in the Cowden disease spectrum suggests that Cowden disease is a true phakomatosis, with hamartomas arising from cutaneous and neural ectoderm. Recent advances in molecular genetics may help to refine the current descriptive classification of the phakomatoses. The association between Lhermitte-Duclos disease and Cowden disease has been under-recognized and under-reported. Recognition of this association has direct clinical relevance, because diligent long-term follow-up monitoring of individuals with Lhermitte-Duclos disease and Cowden disease may lead to the early detection of malignancy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10690726     DOI: 10.1097/00006123-200002000-00021

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  13 in total

1.  Diffusion-weighted MRI in Lhermitte-Duclos disease: report of two cases.

Authors:  Gul Moonis; Mahanad Ibrahim; Elias R Melhem
Journal:  Neuroradiology       Date:  2004-04-16       Impact factor: 2.804

2.  Uncommon low-grade brain tumors.

Authors:  Thankamma Ajithkumar; Naduni Imbulgoda; Elliott Rees; Fiona Harris; Gail Horan; Amos Burke; Sarah Jefferies; Stephen Price; Justin Cross; Kieren Allinson
Journal:  Neuro Oncol       Date:  2019-02-14       Impact factor: 12.300

3.  Coexisting MS and Lhermitte-Duclos Disease.

Authors:  Bria K Casperson; Victor Anaya-Baez; Stephen S Kirzinger; Ronald Sattenberg; Jens O Heidenreich
Journal:  J Radiol Case Rep       Date:  2010-08-01

4.  Lhermitte-Duclos disease associated to Cowden syndrome: de novo diagnosis and management of these extremely rare syndromes in a patient.

Authors:  Ivo Gama; Leonor Almeida
Journal:  BMJ Case Rep       Date:  2017-01-30

Review 5.  Update on neuroimaging phenotypes of mid-hindbrain malformations.

Authors:  Patrice Jissendi-Tchofo; Mariasavina Severino; Béatrice Nguema-Edzang; Cissé Toure; Gustavo Soto Ares; Anthony James Barkovich
Journal:  Neuroradiology       Date:  2014-10-23       Impact factor: 2.804

6.  Acute-onset cerebellar symptoms in Lhermitte-Duclos disease: case report.

Authors:  Omid R Hariri; Arsineh Khachekian; Dan Muilli; Jenny Amin; Tanya Minassian; Blake Berman; Yoav Ritter; Javed Siddiqi
Journal:  Cerebellum       Date:  2013-02       Impact factor: 3.847

7.  Magnetic resonance characteristics of adult-onset Lhermitte-Duclos disease: An indicator for active cancer surveillance?

Authors:  Guangquan Wei; Wei Zhang; Qinlong Li; Xiaowei Kang; Haitao Zhao; Xianping Liu; Xing Tang; Yuanming Wu; Juntao Han; Hong Yin
Journal:  Mol Clin Oncol       Date:  2014-02-12

8.  Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults.

Authors:  Xiao-Ping Zhou; Deborah J Marsh; Carl D Morrison; Abhik R Chaudhury; Marius Maxwell; Guido Reifenberger; Charis Eng
Journal:  Am J Hum Genet       Date:  2003-10-17       Impact factor: 11.025

9.  Contrast enhancement in Lhermitte-Duclos disease of the cerebellum: correlation of imaging with neuropathology in two cases.

Authors:  L Spaargaren; P Cras; M A M Bomhof; S T Lie; A M de Barsy; P H Croese; J L J M Teepen; V H J M Duwel; J W Van Goethem; O Ozsarlak; L van den Hauwe; A M De Schepper; P M Parizel
Journal:  Neuroradiology       Date:  2003-05-16       Impact factor: 2.804

Review 10.  Similar MR imaging characteristics but different pathological changes: a misdiagnosis for Lhermitte-Duclos disease and review of the literature.

Authors:  Shengyue Huang; Guobin Zhang; Junting Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.